You Are Here:
This topic is in the process of being updated. Please go to the Update in Progress section to see the latest documents available.
This topic page summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of cancer.
Release Date: March 2007
- The USPSTF recommends against the routine use of aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) to prevent colorectal cancer in persons at average risk for colorectal cancer.
Grade: D Recommendation.
Recommendation Statement (PDF File, 135 KB; PDF Help)
Evidence Review, Aspirin (PDF File, 300 KB; PDF Help)
Evidence Review, NSAIDs (PDF File, 330 KB; PDF Help)
Evidence Synthesis (PDF File, 3.6 MB; PDF Help)
Update in Progress
In an effort to make the USPSTF recommendations clearer and its processes more transparent, the Task Force is sharing drafts of its draft Research Plans, Evidence Reports, and Recommendation Statements for public comment. As a result, the final Recommendation Statement is not yet available.
USPSTF members work with researchers from an independent Evidence-based Practice Center (EPC) to create a Research Plan that guides the systematic review of the evidence. The Research Plan consists of an analytic framework, key questions, and a literature search strategy or research approach.
|Research Plan||Related Items|
|Final Research Plan||N/A|
Current as of October 2013
Routine Aspirin Use for the Primary Prevention of Cancer, Topic Page. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/uspstf/uspsasco.htm